Point-of-Care Testing for Cardiovascular Disease: A Narrative Review

Xiaolong Liu1,2,3, Mengxiao He4, Rongbo Hu5

  • 1School of Life and Environmental Science, Guilin University of Electronic Technology, Guilin, Guangxi, 541004, China.

PubMed

Insights

Point-of-care testing (POCT) innovations are vital for managing cardiovascular disease. This review analyzes current POCT methods, highlighting their applications, effectiveness, and future potential for early diagnosis and treatment.

Area of Science:

  • Biomedical Engineering
  • Clinical Diagnostics
  • Public Health

Background:

  • Cardiovascular disease (CVD) presents a significant global health burden.
  • Point-of-care testing (POCT) is essential for CVD prevention, early diagnosis, and management.
  • A variety of POCT technologies exist, each with unique applications and performance characteristics.

Purpose of the Study:

  • To provide a comprehensive analysis of current POCT technologies for cardiovascular disease.
  • To assess the effectiveness and limitations of various POCT methods.
  • To offer insights into future research and clinical applications of POCT in CVD.

Main Methods:

  • Review of existing literature on POCT for cardiovascular disease.
  • Analysis of conventional methods, paper-based microfluidics, microfluidic chips, electrochemical, ultrasonic, and smartphone-based detection technologies.
  • Evaluation of performance across different detection scenarios.

Main Results:

  • Diverse POCT technologies demonstrate varied applications and performance in cardiovascular disease detection.
  • Conventional and advanced methods like microfluidics and electrochemical sensors show promise.
  • Smartphone-based technologies offer potential for accessible, widespread use.

Conclusions:

  • POCT technologies are critical for improving cardiovascular disease outcomes.
  • Understanding the strengths and weaknesses of each POCT method is key for clinical implementation.
  • Continued innovation in POCT will drive advancements in cardiovascular care.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
63
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
282
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
769
Acute Coronary Syndrome III: Diagnostic studies01:30

Acute Coronary Syndrome III: Diagnostic studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
109